{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:19:59Z","timestamp":1791814799292,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2_suppl","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular and non-cardiovascular comorbidities are frequently observed in heart failure patients, complicating the therapeutic management and leading to poor prognosis. The prompt recognition of associated comorbid conditions is of great importance to optimize the clinical management, the follow-up, and the treatment of patients affected by chronic heart failure. Anaemia and iron deficiency are commonly reported in all heart failure forms, have a multifactorial aetiology and are responsible for reduced exercise tolerance, impaired quality of life, and poor long-term prognosis. Diabetes mellitus is highly prevalent in heart failure and a poor glycaemic control is associated with worst outcome. Two specific heart failure forms are usually observed in diabetic patients: an ischaemic cardiomyopathy or a typical diabetic cardiomyopathy. The implementation of use of sodium-glucose cotransporter-2 inhibitors will much improve in the near future the long-term prognosis of patients affected by heart failure and diabetes. Among cardiovascular comorbidities, atrial fibrillation is the most common arrhythmic disease of heart failure patients and it is still not clear whether its presence should be considered as a prognostic indicator or as a marker of advanced disease. The aim of the present review was to explore the clinical and prognostic impact of anaemia and iron deficiency, diabetes mellitus, and atrial fibrillation in patients affected by chronic heart failure.<\/jats:p>","DOI":"10.1177\/2047487320960288","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T09:23:26Z","timestamp":1606382606000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":58,"title":["Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation"],"prefix":"10.1093","volume":"27","author":[{"given":"Stefania","family":"Paolillo","sequence":"first","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B","family":"Scardovi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Santo Spirito Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeness","family":"Campodonico","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2021020116494876400_bibr1-2047487320960288","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2019.10.008","article-title":"Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure","volume":"71","author":"Correale","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2021020116494876400_bibr2-2047487320960288","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2021020116494876400_bibr3-2047487320960288","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: Prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"key":"2021020116494876400_bibr4-2047487320960288","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajh.21698","article-title":"Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients","volume":"85","author":"Agostoni","year":"2010","journal-title":"Am J Hematol"},{"key":"2021020116494876400_bibr5-2047487320960288","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/qjmed\/hcv087","article-title":"Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis","volume":"109","author":"Berry","year":"2016","journal-title":"QJM"},{"key":"2021020116494876400_bibr6-2047487320960288","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.ijcard.2012.06.113","article-title":"Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis","volume":"167","author":"Agostoni","year":"2013","journal-title":"Int J Cardiol"},{"key":"2021020116494876400_bibr7-2047487320960288","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease","volume":"12","author":"Von Haehling","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2021020116494876400_bibr8-2047487320960288","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2459\/JCM.0000000000000686","article-title":"Iron deficiency in heart failure","volume":"19","author":"Dinatolo","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2021020116494876400_bibr9-2047487320960288","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"2021020116494876400_bibr10-2047487320960288","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hfc.2019.02.005","article-title":"Anemia and iron deficiency in heart failure: Clinical and prognostic role","volume":"15","author":"Magri","year":"2019","journal-title":"Heart Fail Clin"},{"key":"2021020116494876400_bibr11-2047487320960288","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2016.09.011","article-title":"Heart failure and anemia: Effects on prognostic variables","volume":"37","author":"Cattadori","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2021020116494876400_bibr12-2047487320960288","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"2021020116494876400_bibr13-2047487320960288","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"2021020116494876400_bibr14-2047487320960288","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2459\/JCM.0000000000000736","article-title":"Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: A post-hoc analysis of the IRONOUT-HF trial","volume":"20","author":"Ambrosy","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2021020116494876400_bibr15-2047487320960288","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2021020116494876400_bibr16-2047487320960288","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2021020116494876400_bibr17-2047487320960288","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2021020116494876400_bibr18-2047487320960288","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"Van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2021020116494876400_bibr19-2047487320960288","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2021020116494876400_bibr20-2047487320960288","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC State-of-the-Art Review","volume":"73","author":"McHugh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2021020116494876400_bibr21-2047487320960288","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/euhj.1998.1472","article-title":"Diabetes mellitus and congestive heart failure. Further knowledge needed","volume":"20","author":"Solang","year":"1999","journal-title":"Eur Heart J"},{"key":"2021020116494876400_bibr22-2047487320960288","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/2047487318816774","article-title":"Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community","volume":"26","author":"Gohar","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2021020116494876400_bibr23-2047487320960288","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/2047487318807767","article-title":"Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction","volume":"26","author":"Pavlovic","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2021020116494876400_bibr24-2047487320960288","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"2021020116494876400_bibr25-2047487320960288","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ejhf.44","article-title":"Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure Registry","volume":"16","author":"Johansson","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2021020116494876400_bibr26-2047487320960288","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: Outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"2021020116494876400_bibr27-2047487320960288","article-title":"Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database","author":"Paolillo"},{"key":"2021020116494876400_bibr28-2047487320960288","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: Definition, Diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail Clin"},{"key":"2021020116494876400_bibr29-2047487320960288","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"2021020116494876400_bibr30-2047487320960288","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ejhf.1359","article-title":"The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes","volume":"21","author":"Rorth","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2021020116494876400_bibr31-2047487320960288","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovic","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2021020116494876400_bibr32-2047487320960288","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/2047487319833512","article-title":"Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012","volume":"26","author":"Scalvini","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2021020116494876400_bibr33-2047487320960288","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2459\/JCM.0000000000000896","article-title":"Diabetic patients need higher furosemide doses: A report on acute and chronic heart failure patients","volume":"21","author":"Cunha","year":"2020","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2021020116494876400_bibr34-2047487320960288","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/2047487318820420","article-title":"Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)","volume":"26","author":"Kemps","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2021020116494876400_bibr35-2047487320960288","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.1432","article-title":"A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2021020116494876400_bibr36-2047487320960288"},{"key":"2021020116494876400_bibr37-2047487320960288","article-title":"Effect of dapagliflozin in patients with HFrEF treated with sacubitril\/valsartan: The DAPA-HF trial","author":"Solomon","journal-title":"JACC Heart Fail"},{"key":"2021020116494876400_bibr38-2047487320960288","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"2021020116494876400_bibr39-2047487320960288","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/eurheartj\/ehn361","article-title":"Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients","volume":"29","author":"Agostoni","year":"2008","journal-title":"Eur Heart J"},{"key":"2021020116494876400_bibr40-2047487320960288","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/HCR.0000000000000159","article-title":"Delayed anaerobic threshold in heart failure patients with atrial fibrillation","volume":"36","author":"Palermo","year":"2016","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2021020116494876400_bibr41-2047487320960288","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/2047487314551546","article-title":"Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation","volume":"22","author":"Magri","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2021020116494876400_bibr42-2047487320960288","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejim.2015.04.023","article-title":"Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group","volume":"26","author":"Paolillo","year":"2015","journal-title":"Eur J Intern Med"},{"key":"2021020116494876400_bibr43-2047487320960288","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2018.08.012","article-title":"Dose-dependent efficacy of beta-blocker in patients with chronic heart failure and atrial fibrillation","volume":"273","author":"Campodonico","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2047487320960288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2047487320960288","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/eurjpc\/article-pdf\/27\/2_suppl\/27\/36165402\/eurjpc0027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurjpc\/article-pdf\/27\/2_suppl\/27\/36165402\/eurjpc0027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:41:31Z","timestamp":1698399691000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/27\/2_suppl\/27-34\/6125506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":43,"journal-issue":{"issue":"2_suppl","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2047487320960288","relation":{},"ISSN":["2047-4881","2047-4873"],"issn-type":[{"value":"2047-4881","type":"electronic"},{"value":"2047-4873","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]}}}